VentricHealth’s Vivio System is a rapid, FDA-cleared, non-invasive test that identifies elevated LVEDP at the point of care. The brochure positions Vivio as a way to detect heart failure earlier, improve provider decision-making, and support better patient outcomes and cost savings in primary care.